A method of managing a disorder associated with a
circadian rhythm disorder in a subject by administering to the subject an effective amount of a
beta glucan oligosaccharide and / or an
arabinose oligosaccharide. More specifically, the management includes treating a symptom associated with a
circadian rhythm disorder, primary preventing a symptom associated with a
circadian rhythm disorder, secondary preventing a symptom associated with a circadian
rhythm disorder, and / or delaying progression of a symptom associated with a circadian
rhythm disorder. The symptoms to be managed include symptoms related to sleep, symptoms related to emotion, symptoms related to cognitive function decline and
neurocognitive decline, and the like. In particular methods herein, the risk of developing a symptom associated with a circadian
rhythm disorder in the subject is assessed prior to administration of the
beta glucan oligosaccharide and / or
arabinose oligosaccharide. Also provided are medicaments, nutritional formulations, nutritional supplements and pharmaceutical compositions comprising an effective amount of
beta glucan oligosaccharides and / or
arabinose oligosaccharides for use in such treatment, prevention and
delay.